Back to funds

Rosalind Advisors, Inc.

Updated 6 days ago

Managed by Rosalind Advisors, Inc. • Latest filing Q3 2026

Portfolio value
$311.9M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
99.2%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$284.5M
Q1 2026$248.9M
Q2 2026$269.2M
Q3 2026$311.9M

Top holdings

46 positions as of Q3 2026

View filing
D

DELCATH SYSTEMS, INC.

Value
$52.7M
Shares
3.30M
% Port
16.90%
V

VERASTEM INC

Value
$34.1M
Shares
4.24M
% Port
10.94%
F

FENNEC PHARMACEUTICALS INC

Value
$34M
Shares
3.19M
% Port
10.89%
X

XERIS BIOPHARMA HOLDINGS INC

Value
$24.7M
Shares
2.58M
% Port
7.92%
H

CYBIN INC

Value
$17.1M
Shares
1.39M
% Port
5.47%
S

SAVARA INC

Value
$16.4M
Shares
3.18M
% Port
5.26%
Q

REPLIMUNE GROUP INC

Value
$13.2M
Shares
1.00M
% Port
4.25%
V

VOR BIOPHARMA INC

Value
$11.6M
Shares
609.2K
% Port
3.73%
M

MEDIWOUND LTD

Value
$10.3M
Shares
749.1K
% Port
3.31%
?
10.N/A

X4 PHARMACEUTICALS INC

Value
$9.3M
Shares
3.21M
% Port
2.99%
A

AQUESTIVE THERAPEUTICS INC

Value
$9.3M
Shares
2.00M
% Port
2.97%
P

VAXCYTE INC

Value
$8.5M
Shares
149.4K
% Port
2.73%
T

PROTARA THERAPEUTICS INC

Value
$7.3M
Shares
2.40M
% Port
2.35%
?
14.N/A

MYOMO INC

Value
$6.1M
Shares
3.92M
% Port
1.96%
B

BIOCRYST PHARMACEUTICALS INC

Value
$6M
Shares
721.5K
% Port
1.93%
R

ROCKET PHARMACEUTICALS INC

Value
$5.8M
Shares
2.20M
% Port
1.86%
P

PEPGEN INC

Value
$4.8M
Shares
2.00M
% Port
1.55%
P

PROFOUND MEDICAL CORP

Value
$4.8M
Shares
828.1K
% Port
1.54%
?
19.N/A

TALPHERA INC

Value
$4.8M
Shares
4.13M
% Port
1.54%
N

NEURAXIS INC

Value
$4M
Shares
548.1K
% Port
1.30%

Explore